MTA1 and hepatocellular carcinoma: In our previous work, as well as in other studies, MTA1 has been found to be associated with more aggressive clinicopathological features in patients with HCC, especially in those with HBV-HCC, and thus could be a marker for postoperative early recurrence and poor prognosis in these patients [145,146,147].